Serum Institute Life Sciences (SILS)
-
Biocon Biologics, Serum Institute Life Sciences in strategic alliance
SILS to receive ~15 per cent stake in BBL at a post-money valuation of ~$4.9 billion Biocon Biologics Limited (BBL), a…
Read More »